Nolvaxyl

KALPA PHARMACEUTICALS NOLVAXYL

Nolvaxyl, produced by Kalpa Pharmaceuticals, is a medication containing Tamoxifen Citrate as its active ingredient. It is commonly used in the management of certain types of breast cancer and as a part of post-cycle therapy in bodybuilding.

DRUG COMPOSITION

Each tablet of Nolvaxyl contains:

• Tamoxifen Citrate 20 mg

PHARMACEUTICAL FORM

Nolvaxyl is formulated as oral tablets for easy and convenient administration.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical group: Antiestrogens; ATC code: L02BA01.

PHARMACOLOGICAL PROPERTIES

Tamoxifen Citrate is a selective estrogen receptor modulator (SERM) with both estrogenic and anti-estrogenic properties. It competitively binds to estrogen receptors, inhibiting the effects of estrogen, and is particularly useful in estrogen receptor-positive breast cancer.

PROFILE

• Chemical name: Tamoxifen citrate
• Chemical formula: C32H37NO8
• Percentage of anabolic activity: N/A
• Percentage of androgenic activity: N/A
• Active half life: 5-7 days
• Recommended dosage: 20-40 mg per day
• Acne: Possible
• Bloating (water retention): Rare
• HBR: Low
• Hepatic toxicity: Possible, but rare
• Aromatization: No

THERAPEUTICAL INDICATIONS

Nolvaxyl is indicated for the treatment of:

• Estrogen receptor-positive breast cancer in both pre- and post-menopausal women.
• Adjuvant treatment of early breast cancer.
• Reduction in the risk of invasive breast cancer in women with ductal carcinoma in situ (DCIS) and in women at high risk for breast cancer.

DOSES AND METHOD OF ADMINISTRATION

The dosage and duration of Nolvaxyl treatment should be determined by a healthcare professional. It is usually administered orally with or without food.

CYCLE/STACKING

Solo cycle:

• Weeks 1-5: Nolvaxyl (20 mg daily)

Cutting cycle:

• Weeks 1-8: Testoxyl Propionate 100 (100 mg every other day)
• Weeks 1-8: Nolvaxyl (20 mg daily)

Bulking cycle:

• Weeks 1-10: Dianoxyl 20 (20 mg daily)
• Weeks 1-10: Nolvaxyl (20 mg daily)

POST CYCLE THERAPY

PCT after a cycle with Nandroxyl 250:

• Weeks 1-4: Nolvaxyl (20 mg daily)
• Weeks 1-4: Clomixyl (50 mg daily)

SIDE EFFECTS

Common side effects may include hot flashes, nausea, and fatigue. Serious side effects such as blood clots and uterine cancer are rare.

CONTRAINDICATIONS

Nolvaxyl is contraindicated in individuals with a known hypersensitivity to Tamoxifen Citrate and in those with a history of blood clots.

OVERDOSE

In case of overdose, seek immediate medical attention. Symptoms may include uncontrolled shaking, unsteadiness, and dizziness.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Patients with a history of liver disease or high cholesterol should use Nolvaxyl with caution. Regular monitoring is advised.

INTERACTIONS WITH OTHER DRUGS

Nolvaxyl may interact with certain medications, including warfarin and anastrozole. Inform healthcare providers of all medications being taken.

PRESENTATION, PACKAGING

20 mg/tablet, 30 tablets in sachet.

STORAGE

Store Nolvaxyl at room temperature, away from moisture and light. Keep it out of reach of children.

LEGAL STATUS

Nolvaxyl is available only with a prescription and is subject to the regulations of each jurisdiction.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Kalpa Pharmaceuticals
India

EXTERNAL LINKS

• Tamoxifen Citrate Wiki, wikipedia.org
• Tamoxifen Uses, Dosage, Side Effects, drugs.com
• Tamoxifen CITRATE - Uses, Side Effects, and More, webmd.com.